Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $78.0350 (-1.21%) ($77.7200 - $78.0350) on Fri. Jun. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.5% (three month average) | RSI | 63 | Latest Price | $78.0350(-1.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.1% a day on average for past five trading days. | Weekly Trend | LGND advances 3.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(43%) XBI(43%) PAVE(42%) XAR(42%) XLI(42%) | Factors Impacting LGND price | LGND will decline at least -1.25% in a week (0% probabilities). UUP(-24%) VXX(-15%) TBT(-12%) VIXM(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.25% (StdDev 2.5%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $76.3(2.27%) | 10 Day Moving Average | $75.03(4.01%) | 20 Day Moving Average | $74.17(5.21%) | To recent high | -2% | To recent low | 15.4% | Market Cap | $1.254b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |